Bit Capital Gmb H Kura Oncology, Inc. Transaction History

Bit Capital Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$8.51 - $19.21 $515,969 - $1.16 Million	-60,631 Closed	0 $0
Q3 2024 Feb 12, 2025	BUY	$18.57 - $23.23 $565,400 - $707,283	30,447 Added 100.87%	60,631 $1.18 Billion
Q1 2024 Feb 12, 2025	BUY	$13.42 - $23.53 $405,069 - $710,229	30,184 New	30,184 $644 Million
Q3 2022 Feb 12, 2025	SELL	$12.01 - $19.45 $150,125 - $243,125	-12,500 Closed	0 $0
Q1 2022 Feb 12, 2025	BUY	$11.78 - $16.98 $147,250 - $212,250	12,500 New	12,500 $201 Million

196

84.1M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $558M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.